CENTER FOR INFORMATION AND STUDY O… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2004

Legal Domicile

Principal Officer

CAROLINE CASEY

Phone

6177252750

Tax Period

2024-01-01 to 2024-12-31

CENTER FOR INFORMATION AND STUDY ON CLINICAL RESEARCH PARTICIPATION INC, founded in 2004, is a mid-sized nonprofit in the Medical Research sector that reported $12.7M in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion. Expenses of $11.1M left a modest 13% surplus.

Mission

OUR CORE MISSION IS TO PROVIDE ACCESSIBLE, RELEVANT, USEFUL, HIGH-QUALITY EDUCATIONAL RESOURCES, PROGRAMS, AND SERVICES THAT INCREASE AWARENESS AND UNDERSTANDING OF THE CLINICAL RESEARCH PROCESS; RECOGNIZE AND APPRECIATE THE UNPRECEDENTED GIFT OF PARTICIPATION IN CLINICAL TRIALS; ENHANCE AND ENRICH THE PARTICIPATION EXPERIENCE FOR PATIENTS AND THEIR FAMILIES; AND PROMOTE ENGAGEMENT AND PARTNERSHIP BETWEEN CLINICAL RESEARCH PROFESSIONALS, PATIENTS, AND THE PUBLIC.

Program Service Accomplishments

Program 1

Expenses: $6,064,314 Revenue: $7,770,725

HEALTH COMMUNICATION SERVICES - PROVIDE STUDY VOLUNTEERS WITH THE RESULTS OF THEIR CLINICAL TRIAL BY CREATING AND DELIVERING PLAIN LANGUAGE SUMMARIES, PLAIN LANGUAGE TRANSLATIONS OF INFORMED CONSENT DOCUMENTS, LEGAL DOCUMENTS, WEBSITES, PLAIN LANGUAGE SUMMARIES OF PUBLICATIONS & PROTOCOL SYNOPSES. HEALTH LITERACY EDUCATION AND WORKSHOPS.

Program 2

Expenses: $2,030,077 Revenue: $4,019,860

RESEARCH SERVICES - ENGAGING PATIENTS AND THEIR SUPPORT NETWORK TO OBTAIN MEANINGFUL INSIGHTS FOR SPONSORS - INCLUDING BUT NOT LIMITED TO PHARMACEUTICAL, BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES...

RESEARCH SERVICES - ENGAGING PATIENTS AND THEIR SUPPORT NETWORK TO OBTAIN MEANINGFUL INSIGHTS FOR SPONSORS - INCLUDING BUT NOT LIMITED TO PHARMACEUTICAL, BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES, CONTRACT RESEARCH ORGANIZATIONS, ACADEMIC AND FOR-PROFIT INSTITUTIONS, FOUNDATIONS AND NONPROFIT ORGANIZATIONS. PROVIDE PATIENT & CARE PARTNER ADVISORY BOARDS, CLINICAL TRIAL JOURNEY WORKSHOPS, AND CUSTOM RESEARCH PROJECTS.

Program 3

Expenses: $617,040 Revenue: $217,563

CONTENT LICENSING - LICENSING OR PURCHASE OF CISCRP EDUCATIONAL CONTENT, VIDEOS AND BROCHURES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $694,061

Program Service Revenue $12,008,148

Investment Income $44,982

Other Revenue $0

TOTAL REVENUE $12,747,191

Expense Breakdown

Grants Paid $0

Salaries & Benefits $5,723,862

Fundraising Expenses $318,202

Program Expenses $9,390,926

Other Expenses $5,382,262

TOTAL EXPENSES $11,106,124

Year-over-Year Comparison

	2024	2023	Change
Revenue	$12,747,191	$11,669,707	+0.1%
Expenses	$11,106,124	$10,637,071	+0.0%
Net Income	$1,641,067	$1,032,636	+0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$371,291

Total Directors

$87,983

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KENNETH GETZ	BOARD CHAIR	8.00	Officer Director	$87,983	$0	$87,983
JORGE GUERRA	BOARD MEMBER	0.10	Director	$0	$0	$0
JESSICA BLAUSTEIN	BOARD MEMBER	0.10	Director	$0	$0	$0
LEANNE MADRE	BOARD MEMBER	0.10	Director	$0	$0	$0
CAROLINE CASEY	CFO & COO	40.00	Officer	$249,474	$33,834	$283,308
JULIA FARIDES MITCHELL	DIRECTOR, HEALTH COMM. SERVICES	40.00	Highest	$128,855	$5,561	$134,416
ANNICK DEBRUIN	CHIEF RESEARCH AND INSIGHTS OFFICER	40.00	Highest	$226,892	$24,198	$251,090
KIM EDWARDS	SR. DIRECTOR, HEALTH COMM. SERVICES	40.00	Highest	$144,502	$27,322	$171,824
TRICIA BRAMLEY	DIRECTOR, MARKETING, COMM., & EDUCATION	40.00	Highest	$126,306	$13,208	$139,514
BEHTASH BAHADOR	DIRECTOR, HEALTH LITERACY	40.00	Highest	$126,107	$26,704	$152,811

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$12,747,191	$11,106,124	$8,399,697	$1,641,067
2023	$11,669,707	$10,637,071	$7,667,635	$1,032,636
2022	$8,654,803	$8,577,457	$6,262,145	$77,346
2021	$9,262,941	$8,578,464	$5,283,770	$684,477
2020	$7,850,270	$6,565,450	$4,767,267	$1,284,820
2019	$5,807,797	$5,422,945	$3,000,441	$384,852
2018	$4,025,358	$4,117,184	$2,368,595	$-91,826

CENTER FOR INFORMATION AND STUDY ON CLINICAL RESEARCH PARTICIPATION INC